Arimidex 1 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FX35U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,900
Award facts
- Contract value 100% obligated
- $3,899.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,899.66 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging). The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This award is issued as a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables global pharmaceutical support across multiple therapeutic domains for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Logistics Agency and Defense Health Agency. The company maintains an extensive portfolio of federal pharmaceutical contracts covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. All of the company's reviewed contract awards have been competitively awarded without set-asides, demonstrating its capability to compete successfully for federal medical supply requirements. This particular delivery order for Arimidex, a hormone therapy medication used in cancer treatment, exemplifies the company's role in supporting military and veteran healthcare supply chains through the DLA's pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DB25FX35U?
SPE2DB25FX35U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FX35U worth?
The government has obligated $3,900 on SPE2DB25FX35U.
Is contract SPE2DB25FX35U an order under another contract?
Yes. SPE2DB25FX35U is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX35U competed?
The extent of competition for SPE2DB25FX35U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award